Anti-tTG IgA Test Purpose, Procedure, Principle, Result Interpretation, Report Formate and Clinical Signification

The Anti-tTG IgA assay is a class-specific immunological test designed to detect IgA autoantibodies directed against tissue transglutaminase (tTG), a calcium-dependent enzyme involved in post-translational protein modification. The test serves as the primary serological marker for immune-mediated gluten-related enteropathies and is widely used in laboratory autoimmune screening algorithms.

Anti TTG Test Types:

1. Anti-TTG IgA Test:
   • This test measures IgA (immunoglobulin A) antibodies against tissue transglutaminase.
   • IgA antibodies are commonly used because they are found in the mucous membranes of the gastrointestinal tract, which is where celiac disease primarily affects.
   • It is the primary form of the Anti-TTG antibody test and is considered highly specific for celiac disease diagnosis.
   • Results are typically reported in units such as U/mL (units per milliliter) or IU/mL (international units per milliliter).
2. Anti-TTG IgG Test:
   • In some cases, individuals with celiac disease may have IgA deficiency, which can lead to false-negative results on the Anti-TTG IgA test.
   • In such cases, the Anti-TTG IgG test is used to detect IgG antibodies against tissue transglutaminase.
   • This test is often used as an alternative when IgA deficiency is suspected or confirmed.
   • Results are also reported in units such as U/mL or IU/mL.

Principle of the Test

The ATTG IgA assay is based on a solid-phase antigen–antibody immunological reaction.

ELISA Principle

• Microtiter wells are coated with recombinant human tissue transglutaminase antigen
• IgA antibodies in patient serum bind specifically to immobilized tTG
• An enzyme-labeled anti-human IgA conjugate binds to the antigen–antibody complex
• Addition of chromogenic substrate (TMB) results in color formation
• Reaction is stopped using acid stop solution
• Color intensity is proportional to IgA antibody concentration
• Absorbance measured at 450 nm (reference 620–630 nm)

Method Type:

• Immunoassay
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Chemiluminescent Immunoassay (CLIA)
  • Fluorescence Enzyme Immunoassay (FEIA)

Clinical Significance (Technical)

Elevated ATTG IgA

• Indicates loss of immune tolerance to tissue transglutaminase
• Reflects IgA-mediated autoimmune mucosal injury
• Antibody titers correlate with:
  • Degree of intestinal villous atrophy
  • Severity of immune-mediated inflammation
• High specificity makes it the preferred first-line serological assay

Low or Undetectable ATTG IgA

• Absence of detectable IgA-mediated immune response
• May be seen in:
  • Early disease
  • Treated or inactive disease
  • Selective IgA deficiency
• Requires correlation with total serum IgA

Specimen Requirements

Patient Preparation (Technical)

• No fasting required
• Sample collection prior to initiation of immunosuppressive therapy is preferred
• Gluten exposure influences antibody titers
• Recent blood transfusion may interfere
• Avoid repeated freeze–thaw cycles

Reagents & Materials Required

Reagents

• Recombinant human tTG-coated microtiter wells
• Anti-human IgA enzyme conjugate (HRP-labeled)
• TMB chromogenic substrate
• Stop solution (0.5–1N sulfuric acid)
• Wash buffer (phosphate-buffered saline with surfactant)

Calibrators

• Multi-level IgA Anti-tTG calibrators traceable to manufacturer reference standards

Controls

• Negative (normal) control
• Low positive control
• High positive (pathological) control

Equipment

• Centrifuge
• ELISA washer
• Microplate reader
• Automated immunoassay analyzer (if applicable)
• Micropipettes with disposable tips
• Incubator (37 °C)
• Timer

Required Wavelength

• Primary: 450 nm
• Reference: 620–630 nm

Reagent Storage

• Store at 2–8 °C
• Do not freeze conjugates or coated plates
• Protect TMB from light

Test Procedure (Step-by-Step)

A. Manual ELISA Method

1. Allow reagents and samples to reach room temperature
2. Add 100 µL calibrators, controls, and samples to designated wells
3. Incubate at 37 °C for 30 minutes
4. Wash wells 3–5 times with wash buffer
5. Add 100 µL anti-IgA enzyme conjugate
6. Incubate at 37 °C for 30 minutes
7. Wash thoroughly
8. Add 100 µL TMB substrate
9. Incubate 10–15 minutes in the dark
10. Add 100 µL stop solution
11. Measure absorbance at 450 nm

B. Automated Method

• Load samples, reagents, calibrators, and controls
• Program assay protocol as per analyzer instructions
• Calibration frequency: with new reagent lot or QC failure
• Analyzer performs incubation, washing, detection
• On-board reagent stability: typically 7–14 days (method-dependent)

Calculation Formula

Manual ELISA Calculation

$$\text{ATTG IgA (IU/mL)} = \frac{\text{Sample Absorbance}}{\text{Calibrator Absorbance}} \times \text{Calibrator Value}$$ATTG IgA (IU/mL)=Calibrator AbsorbanceSample Absorbance​×Calibrator Value

Units: IU/mL

Worked Example:
Sample OD = 1.10
Calibrator OD = 0.88
Calibrator = 10 IU/mL
Result = 12.5 IU/mL

Reference Ranges

Reference ranges must be validated by each laboratory.

Interpretation (Technical / Professional)

High Levels

• IgA-mediated autoimmune response against tTG
• Active immune-mediated mucosal injury
• Correlates with:
  • Anti-endomysial antibodies
  • Elevated inflammatory markers
  • Malabsorption-associated biochemical abnormalities

Low Levels

• Absence of IgA autoantibody response
• Possible selective IgA deficiency
• Early or treated disease state

Interfering Factors / Sources of Error

• Hemolysis → false elevation
• Lipemia → optical interference
• Icterus / high bilirubin
• Immunosuppressive drugs → decreased titers
• Delayed serum separation
• Sample contamination
• Incorrect anticoagulant
• Temperature variation
• Improper mixing
• Instrument drift

Quality Control Requirements

• QC Levels: Negative, Low Positive, High Positive
• Frequency: Daily or per analytical run
• Acceptable ranges: Manufacturer-defined
• Apply Westgard rules (1-2s, 2-2s, R-4s)
• Maintain Levey–Jennings charts
• Corrective actions: repeat QC, recalibrate, replace reagents

Calibration Requirements

• Multi-level calibration
• Perform with:
  • New reagent lot
  • Analyzer maintenance
  • QC failure
• Linearity: typically up to ~200 IU/mL
• Recalibrate if drift or non-linearity observed

Instrument Maintenance Notes

• Daily: Probe wash, system rinse
• Weekly: Optical inspection, wash system cleaning
• Monthly: Temperature verification, carryover assessment

🧠 AI-Powered Test Result Analysis:

Critical (Panic) Values

• 100 IU/mL (method-dependent)

Follow institutional policy for notification.

Troubleshooting Guide

Safety Precautions

• Use PPE (gloves, lab coat, eye protection)
• Treat all specimens as biohazardous
• Dispose waste per biosafety protocols
• Follow MSDS for reagents
• Avoid aerosol generation and cross-contamination

Test Limitations

• False negatives in selective IgA deficiency
• Cross-reactivity with other autoimmune antibodies
• Non-specific reactions at very high titers
• Method-dependent sensitivity and specificity
• Not diagnostic as a standalone test

Notes for Lab Students

• ATTG IgA is the primary screening assay
• Always verify QC before reporting
• Strict incubation timing is critical
• Always correlate with total IgA levels

FAQs:

References (Technical)

• CLSI Immunoassay Guidelines
• WHO Laboratory Quality Manuals
• IFCC Autoimmune Diagnostics Documentation
• Manufacturer ELISA / CLIA Package Inserts
• Peer-reviewed Immunology Journals

Possible References Used